InvestorsHub Logo
Followers 16
Posts 1282
Boards Moderated 0
Alias Born 04/23/2020

Re: Itchy palm post# 134390

Friday, 12/18/2020 10:51:37 AM

Friday, December 18, 2020 10:51:37 AM

Post# of 233137
MESO failed because their trial endpoint was 43% reduction in mortality at 30 days. This is very hard to prove now. If you read their PR it goes into detail.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News